The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study | Autoimmunity Reviews | 2020 | 38 |
Cardiovascular/stroke risk predictive calculators: a comparison between statistical and machine learning models | Cardiovascular Diagnosis and Therapy | 2020 | 31 |
Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic | Annals of the Rheumatic Diseases | 2020 | 30 |
Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity | Cell Metabolism | 2020 | 28 |
Increased adenosine-to-inosine RNA editing in rheumatoid arthritis | Journal of Autoimmunity | 2020 | 24 |
Effects of Interleukin 17A Inhibition on Myocardial Deformation and Vascular Function in Psoriasis | Canadian Journal of Cardiology | 2020 | 22 |
Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors | Rheumatology | 2020 | 21 |
Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes | Rheumatology International | 2020 | 19 |
Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention | Current Vascular Pharmacology | 2020 | 19 |
Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development | Frontiers in Immunology | 2020 | 17 |
Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations | Therapeutic Advances in Musculoskeletal Disease | 2020 | 17 |
Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the 'Attikon' cohort | Lupus | 2020 | 17 |
Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection | Vaccine | 2020 | 15 |
Does the Carotid Bulb Offer a Better 10-Year CVD/Stroke Risk Assessment Compared to the Common Carotid Artery? A 1516 Ultrasound Scan Study | Angiology | 2020 | 14 |
TREX1 variants in Sjogren's syndrome related lymphomagenesis | Cytokine | 2020 | 13 |
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study | Advances in Therapy | 2020 | 12 |
Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2020 | 12 |
The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial | RMD Open | 2020 | 11 |
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease | Seminars in Arthritis and Rheumatism | 2020 | 11 |
Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study | International Journal of Cardiology | 2020 | 11 |
Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome | Autoimmunity Highlights | 2020 | 10 |
Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus | European Journal of Preventive Cardiology | 2020 | 10 |
Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors | Therapeutic Advances in Musculoskeletal Disease | 2020 | 10 |
Cell-autonomous epithelial activation of AIM2 (absent in melanoma-2) inflammasome by cytoplasmic DNA accumulations in primary Sjögren's syndrome | Journal of Autoimmunity | 2020 | 9 |
Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis | Frontiers in Immunology | 2020 | 9 |